
Cyclosporine: A strong oral immune-suppressing drug used in short bursts for severe eczema and psoriasis. It works faster than anything else, and blood pressure and kidney function set a hard limit on how long anyone stays on it. Elidel: A steroid-free anti-inflammatory cream for eczema. It calms the immune reaction in the skin without thinning it, which is why it is used on the face, eyelids and skin folds.


Choose for a fast, short burst of control in severe eczema or psoriasis while a longer-term treatment is set up.
Choose for eczema on delicate skin — face, eyelids, folds — when you want to avoid steroid thinning.
Can you take them together?
Elidel can be used on the face or folds during a cyclosporine course. Very little Elidel reaches the blood.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Inhibits calcineurin: Binds cyclophilin to block a T-cell activation switch. Reduces IL-2 signals: Limits a messenger that helps T cells become active. Calms skin inflammation: Overactive immune responses in skin decrease.
Cyclosporine binds cyclophilin; that complex inhibits calcineurin and T-cell cytokine production. This is a simplified skin-focused explanation of systemic immunosuppression.

Inhibits calcineurin: Blocks a switch that helps activate T cells. Reduces immune messengers: T cells release fewer inflammation-driving signals. Calms eczema and itch: Redness and irritation ease as inflammation settles.
The drug binds FKBP-12 and inhibits calcineurin, reducing T-cell cytokine transcription; the complete atopic-dermatitis mechanism is not known. It also has other cellular effects.
The dose is set by body weight, then adjusted by blood pressure and kidney tests, not by how the skin looks.
Starting dose: About 2.5 mg per kilogram of body weight a day, split into two doses. A severe flare may start around 4 to 5 mg per kilogram a day to get control quickly.
Going up: Raised in small steps every two to four weeks if response is poor, and only if the tests are stable.
Coming down: Once the skin is calm, the dose comes down in stages, to give the next treatment time to work.
Total course: Short by design. Many courses run 8 to 16 weeks. Guidelines advise no more than about a year of continuous treatment, less where possible.
When to Apply: A thin layer twice a day on the affected skin. Rub it in until it disappears. Moisturizer can go on top or underneath.
How to Start: Twice daily as soon as a flare starts, and keep going until the skin is clear rather than merely better. Many people then move to two or three days a week on the spots that always come back, to head off the next flare. Discuss that with your doctor.
If It Irritates: Warmth, stinging or burning for the first few days is the commonest complaint. It happens because the skin is inflamed, not because you are allergic, and it usually stops within a week as the eczema settles. Keeping the cream in the fridge, moisturizing first, or starting once a day for a few days makes it easier.
If It's Not Working: Nothing to increase — there is one strength. Give it six weeks of consistent twice-daily use. If the skin is no better, the usual next steps are a short steroid course to reset it, a switch to tacrolimus ointment, or a newer non-steroid cream.
Twice a day, about 12 hours apart, at the same times daily. Be consistent about food: always with meals or always without, because switching changes absorption. Swallow capsules whole and leave them in the foil until you take them.
On the liquid, mix it with orange or apple juice in a glass cup, stir and drink it straight away, then rinse the cup with more juice and drink that too. Never use grapefruit juice.
Take it when you remember unless the next dose is close, then skip it. Never take two at once. Tell the prescriber if you miss more than a dose or two, or vomit soon after taking it, because the dose is built around your blood level.
Cyclosporine is monitored more closely than any other skin drug, and that monitoring is why it can be used at all. Blood pressure is measured at every visit, often at home. Kidney function is checked by blood test, twice before starting for a reliable baseline, then every couple of weeks for a month or two, then monthly once the dose is steady. The same draws cover potassium, magnesium, uric acid, liver enzymes, blood counts and cholesterol. Drug blood levels are routine in transplant care, not usually needed at dermatology doses.
Two numbers drive the decisions. A rise in creatinine of about a quarter above your baseline, confirmed on a repeat test, means dropping the dose; about half means stopping. New high blood pressure means lowering the dose or adding a blood pressure medicine, and the choice matters: diltiazem and verapamil push levels up, amlodipine does not.
The interaction list is long. Drugs that raise levels include the azole antifungals, clarithromycin and erythromycin, and some HIV and hepatitis C medicines. Drugs that lower it include rifampin, phenytoin, carbamazepine and St John's wort. It also raises statin levels, so that dose is often reduced, and it interacts with colchicine, digoxin, methotrexate and potassium-sparing water tablets. Bring every prescription, supplement and herbal product to the first visit.
The time limit is the point of all this. Kidney damage builds with continuous use and part of it can be permanent, so guidelines cap continuous treatment at about a year and most dermatology courses are far shorter. Long or repeated use also raises the risk of skin cancer, lymphoma and serious infection, so skin checks continue afterward.
No routine blood tests. Blood levels are very low or undetectable, and it does not affect the adrenal glands the way strong steroids do.
Monitoring is a conversation at six weeks, then longer intervals if you stay on it. Your doctor is checking whether the eczema is actually controlled, whether steroid rescue courses have been needed often enough to suggest a change of plan, and whether any patch of skin is behaving oddly rather than simply eczema.
Because of the boxed warning, most dermatologists look harder at any new or changing spot in long-term users rather than assuming it is part of the rash. Registry follow-up has not found the increase in skin cancer or lymphoma the warning anticipated, so this is ordinary caution, not surveillance for a known risk.
Approximate windows, not promises.
First 2 weeksStarting: Itch settles first, often within days, and sleep improves. Tingling or burning in the hands and feet, headache and mild nausea are common early. Blood pressure and kidney tests get checked.
Weeks 2 to 6Working: Redness, weeping and thickness improve clearly. Chronic hives that antihistamines do not control usually settle within a month. Extra hair growth on the face, arms and body and swollen or tender gums start now; both are dose-related and reverse after stopping.
Weeks 2 to 6Judge it here: The rash flattens and clears. The fair point to decide whether it is doing enough.
Weeks 8 to 16Plaque psoriasis: Large improvement, often near-clear at the higher end of the dose range. Usually where the course ends and another treatment takes over.
VariableSevere inflammatory ulcers: In pyoderma gangrenosum it stops the ulcer spreading while healing catches up. Response times differ a lot.
ThroughoutThe tests: Blood pressure creeping up and kidney numbers drifting decide whether the dose drops or the drug stops. Neither causes symptoms, which is why the tests are not optional.
First few minutesApplying it: A thin layer twice a day. Warmth or stinging for a few minutes, strongest on the rawest skin.
Days 1 to 5Adjusting: The stinging is at its worst now and fades as the skin heals. Itch often eases while the rash looks the same.
Weeks 1 to 2Working: Redness fades, skin feels less tight. Night scratching drops off first.
Face, eyelids and foldsIts strongest use: Thin skin is where steroids cause the most trouble, so a non-thinning option is worth losing some strength. Armpits, groin and under the breasts thin quickly too.
OngoingHolding: Once clear, many drop to two or three applications a week on the areas that always flare. No thinning means no time limit.
Sorted by what to do about them.
Generic capsules are cheap next to biologics, part of why the drug is still used. Branded versions cost more without working better.
The visible cost is not the whole cost. Repeated blood tests, blood pressure checks and appointments add up, and none are optional. It is cheaper per month than a biologic but taken for only a few months, so the comparison depends on what comes after.
Insurance generally covers it for severe psoriasis. Eczema coverage varies more in the United States, where that use is off-label.
Cost has improved. Generic pimecrolimus cream brought the price down from one of the more expensive eczema treatments to something ordinary. Brand-name Elidel is still costly.
The usual obstacle is not price but step therapy. Because the label calls it second-line, many plans want to see that a topical steroid was tried and failed, or a reason a steroid should not be used, before covering it. A note from your doctor saying the eczema is on the eyelids or in the folds usually settles that.
Cash prices for the generic vary between pharmacies more than most drugs, so check a discount card price before assuming you cannot afford it. Tube size matters too — a large tube is often better value per gram, and eczema treatment runs longer than people expect.
Faster than anything else for these conditions. Itch improves within days, clearing by four to six weeks.
Most courses run months. Guidelines cap continuous use at about one year, because kidney effects build and some can be permanent.
It raises blood pressure in a meaningful share of people, and that causes no symptoms. Catching it early usually means lowering the dose rather than stopping.
No. Grapefruit, pomelo and Seville oranges block the enzyme that clears it, so levels rise unpredictably. Other citrus is fine.
Both are dose-related. Not dangerous, usually better if the dose comes down, and gone after stopping.
Usually, within weeks to a few months, unless another treatment is running. Planning that before the taper is the point of the short course.
No. Different pathway, and it does not thin the skin — the whole reason it is used on eyelids, the face and skin folds.
Because at approval regulators noted that related medicines suppress immunity body-wide in transplant patients, that very high oral doses caused tumors in animals, and that a small number of cancer reports existed in users. The warning states that long-term safety is not established — a precaution, not a finding. Follow-up since has not shown an increased rate of skin cancer or lymphoma.
Because the skin underneath is inflamed. It is the commonest side effect, strongest in the first few days, and it settles as the eczema heals. Moisturizing first or chilling the tube helps.
No fixed limit. It does not thin skin, so it can run in repeated courses, or two or three times a week, for years with review.
Yes — eyelids are one of its main uses, one of the few anti-inflammatory options that can go there repeatedly without thinning skin or raising eye pressure.
No. Tacrolimus 0.1% ointment is more powerful for moderate eczema. Pimecrolimus is better tolerated and cosmetically easier, so it is often the one people keep using.